Factors associated with antenatal depression during the COVID‐19 (SARS‐CoV2) pandemic: A cross‐sectional study in a cohort of Turkish pregnant women
Abstract
Abstract Purpose To determine the effect of the COVID‐19 pandemic on antenatal depression in Turkish pregnant women. Design and Methods In this cross‐sectional study, data were collected from 497 pregnant women between May and July 2020 using the Edinburgh Depression Scale (EDS) to determine the effect of obstetrics history, fear of hospitalization, concerns about the pandemic, birth, and the health of both mother and infant, on antenatal depression during the COVID‐19 outbreak in Turkey. Findings The general EDS mean score of the total group was determined as mean 13.70 ± 6.22, which was higher than the critical cutoff point of 13. According to the multiple linear regression model applied in the study, the best predictive variables for the mean EDS score were determined to be concerned about completing a healthy pregnancy (r = −0.45), social media and news programs related to COVID‐19 increasing levels of concern (r = −0.31), fear of hospitalization as the birth approaches (r = −0.45), having bad dreams during the COVID‐19 pandemic (r = −0.41), the request for an elective cesarean delivery because of fear of catching COVID‐19 (r = −0.40), fear of breastfeeding the infant (r = −0.45), and concerns that their own health would be negatively affected because of the pandemic (r = − 0.39), and these variables affected the mean EDS score negatively (total variance 40.5%, R = 0.642). Practical Implications The COVID‐19 pandemic has created an urgent need to implement specific…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 497 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.